BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 11504092)

  • 1. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
    Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
    Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
    Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA.
    Papantoniou V; Sotiropoulou M; Stipsaneli E; Louvrou A; Feda H; Christodoulidou J; Pampouras G; Zerva C; Keramopoulos A; Michalas S
    Clin Nucl Med; 2000 Jun; 25(6):434-9. PubMed ID: 10836691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
    Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
    J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
    Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
    J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions.
    Yildiz A; Colak T; Güngör F; Ozuğur S; Boz A; Tunçdemir F; Akaydin M
    Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
    Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
    Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement.
    Myslivecek M; Koranda P; Kamínek M; Husák V; Hartlová M; Dusková M; Cwiertka K
    Nucl Med Rev Cent East Eur; 2004; 7(2):151-5. PubMed ID: 15968602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia.
    Papantoniou V; Valsamaki P; Sotiropoulou E; Tsaroucha A; Tsiouris S; Sotiropoulou M; Marinopoulos S; Kounadi E; Karianos T; Fothiadaki A; Archontaki A; Syrgiannis K; Ptohis N; Makris N; Limouris G; Antsaklis A
    Mol Imaging; 2011 Oct; 10(5):370-6. PubMed ID: 21521552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
    Palmedo H; Bender H; Grünwald F; Mallmann P; Zamora P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1997 Sep; 24(9):1138-45. PubMed ID: 9283107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Ma Q; Chen B; Gao S; Ji T; Wen Q; Song Y; Zhu L; Xu Z; Liu L
    PLoS One; 2014; 9(9):e108349. PubMed ID: 25250628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
    Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of Calcitonin Gene-Related Peptide (CGRP) in breast carcinogenesis and its correlation with 99mTc-(V)DMSA scintimammography.
    Papantoniou V; Tsiouris S; Sotiropoulou M; Valsamaki P; Koutsikos J; Ptohis N; Dimitrakakis C; Sotiropoulou E; Melissinou M; Nakopoulou L; Antsaklis A; Zerva C
    Am J Clin Oncol; 2007 Aug; 30(4):420-7. PubMed ID: 17762443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
    Cistaro A; Bonazzi G; Bellò M; Bessone M; Tetti M; Villata E; Coluccia C; Bisi G; Massaioli N
    Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
    Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
    Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.